Timeline of Changes After Stopping Week 12: Hunger and cravings begin to return You may notice food on your mind more often Energy levels may dip slightly Week 24: Digestion speeds up again Blood sugar may rise, especially if you have diabetes Some weight regain may begin Month 13: Appetite returns to pre-treatment levels Greater risk of significant weight regain Blood sugar and metabolism return to baseline Common Withdrawal Experiences & Symptoms Physical changes: Increased hunger and food cravings Feeling hungrier sooner after meals Blood sugar fluctuations (important for those with diabetes) Possible nausea as eating patterns shift Emotional and mental changes: Worry or anxiety about weight regain Feeling disappointed if stopping wasnt your choice Relief from side effects, but new concerns about what comes next Why Medical Support Matters Your body doesnt flip a switch when you stop GLP-1s
Consider timing injections for evenings so peak side effects occur during sleep
You may be a good candidate if you: Have a body mass index (BMI) of 30 or higher Have a BMI of 27 or higher with weight-related conditions such as hypertension, diabetes, or metabolic syndrome Have difficulty losing weight through diet and exercise alone Want a medically supervised weight loss program for long-term success At Henderson Womens Care, we evaluate each patients medical history, lifestyle, and weight loss goals to determine if semaglutide or tirzepatide are the right options
Tirzepatide (Mounjaro/Zepbound), the dual GLP-1/GIP agonist, has 2-3 years of real-world experience with roughly 5-7 million patients and shows a similar pattern of sustained effectiveness
20 BellGISanchez-PescadorRLaybournPJNajarianRC
